VERTEX PHARMACEUTICALS INCORPORATED for VERTEX PHARMACEUTICALS INCORPORATED
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Regulatory and legislative issues related to the U.S. Food and Drug Administration; appropriations for the U.S. Food and Drug Administration, the National Institutes of Health and the U.S. Centers for Disease Control; Medicare and Medicaid reimbursement issues; regulatory and legislative issues related to the U.S. Patent and Trademark Office.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EUSTACIA LEE REIDY New | N/A |
| AMIT K SACHDEV New | HOUSE CMTE ON (ENERGY AND) COMMERCE, MAJORITY COUNSEL; |
Health Issues HCR
Regulatory and legislative issues related to the U.S. Food and Drug Administration; appropriations for the U.S. Food and Drug Administration, the National Institutes of Health and the U.S. Centers for Disease Control; Medicare and Medicaid reimbursement issues; regulatory and legislative issues related to the U.S. Patent and Trademark Office.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EUSTACIA LEE REIDY New | N/A |
| AMIT K SACHDEV New | HOUSE CMTE ON (ENERGY AND) COMMERCE, MAJORITY COUNSEL; |
Medicare/Medicaid MMM
Regulatory and legislative issues related to the U.S. Food and Drug Administration; appropriations for the U.S. Food and Drug Administration, the National Institutes of Health and the U.S. Centers for Disease Control; Medicare and Medicaid reimbursement issues; regulatory and legislative issues related to the U.S. Patent and Trademark Office.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EUSTACIA LEE REIDY New | N/A |
| AMIT K SACHDEV New | HOUSE CMTE ON (ENERGY AND) COMMERCE, MAJORITY COUNSEL; |
Budget/Appropriations BUD
Regulatory and legislative issues related to the U.S. Food and Drug Administration; appropriations for the U.S. Food and Drug Administration, the National Institutes of Health and the U.S. Centers for Disease Control; Medicare and Medicaid reimbursement issues; regulatory and legislative issues related to the U.S. Patent and Trademark Office.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EUSTACIA LEE REIDY New | N/A |
| AMIT K SACHDEV New | HOUSE CMTE ON (ENERGY AND) COMMERCE, MAJORITY COUNSEL; |
Medical/Disease Research/Clinical Labs MED
Regulatory and legislative issues related to the U.S. Food and Drug Administration; appropriations for the U.S. Food and Drug Administration, the National Institutes of Health and the U.S. Centers for Disease Control; Medicare and Medicaid reimbursement issues; regulatory and legislative issues related to the U.S. Patent and Trademark Office.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EUSTACIA LEE REIDY New | N/A |
| AMIT K SACHDEV New | HOUSE CMTE ON (ENERGY AND) COMMERCE, MAJORITY COUNSEL; |
Science/Technology SCI
Regulatory and legislative issues related to the U.S. Food and Drug Administration; appropriations for the U.S. Food and Drug Administration, the National Institutes of Health and the U.S. Centers for Disease Control; Medicare and Medicaid reimbursement issues; regulatory and legislative issues related to the U.S. Patent and Trademark Office.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EUSTACIA LEE REIDY New | N/A |
| AMIT K SACHDEV New | HOUSE CMTE ON (ENERGY AND) COMMERCE, MAJORITY COUNSEL; |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.